Specialty Pharmacies Have Many Roles to Play During Outbreak

As the COVID-19 pandemic continues its assault on the globe and the U.S. passes 12,000 deaths from it, all eyes are on the health care industry. While the public looks to pharma manufacturers for potential treatments and vaccines, labs for testing to detect the virus, and providers and others in their realm for being on the front line of the defense against it, specialty pharmacies still have a vital role to play.

“During this unprecedented time, specialty pharmacies need to be nimble and possess the flexibility necessary to continue serving patients while keeping team members safe,” says John Stephens, vice president, transformation and growth at AllianceRx Walgreens Prime. At that specialty pharmacy, 75% of employees are working from home, with the rest “still working on site to dispense and ship lifesaving medications. Ship-to-home is the basic skill or capability keeping people out of pharmacies and hospitals, especially since specialty patients are more at risk due to the pandemic.”

© 2024 MMIT
Angela Maas

Angela Maas

Angela has an extensive background of editing, reporting and writing for trade and consumer publications. She has written Radar on Specialty Pharmacy (formerly called Specialty Pharmacy News) since she joined AIS Health in 2005 and has broad knowledge of the various issues at play within the space. Before joining AIS Health, she was managing editor at Employee Benefit News and Employee Benefit News Canada and managing editor at HemAware (a hemophilia publication), Lupus Living and Momentum (a multiple sclerosis publication). She has a B.A. in English and an M.A. in British literature from Arizona State University.

Related Posts

businessman-viewing-news-update-journalism-headline-on-a-laptop
April 11

News Briefs: Amylyx Is Withdrawing ALS Drug Relyvrio in U.S., Canada

READ MORE
fda-approved-rubber-stamp-with-fda-and-pills-on-craft-paper
April 11

New FDA Approvals: FDA Approves BeiGene’s Tevimbra

READ MORE
test-tube
April 11

‘Significant Milestone’ Brings New Weapon to Advanced Melanoma Fight

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today